Summary List Placement
On Monday, Moderna, a Cambridge, Massachusetts-based biotechnology company, announced that its mRNA-1273 vaccine, developed in partnership with the US government, appeared to be 94.5% effective against the novel coronavirus.
It was a major breakthrough in modern science. And it was made possible in part because of an immigrant from the Middle East named Noubar Afeyan.
The 58-year-old is the cofounder and chairman of Moderna, and founder and CEO of the venture-capital firm backing the company, Flagship Pioneering. Born in Beirut to Armenian parents, he moved to Canada to study at McGill University in Montreal.
“As a teenager
Read more Source: businessinsider.com